IP Library Granted Patent US 8,415,460
Granted Patent B2
US 8,415,460 · App. 12/484,053 · Granted Apr 9, 2013

Methods of making antibodies specific for cysteine-rich soluble protein C23

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,415,460
App. No.
12/484,053
Granted
Apr 9, 2013
Kind
B2
Abstract

Nucleic acids encoding a new family of small cysteine rich soluble proteins, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.

Claims (2)

1. A method of making an antibody that specifically binds to a C23 polypeptide comprising the amino acid sequence of residues 1-90 of SEQ ID NO: 2, said method comprising immunizing an immune system with an immunogenic amount of a C23 polypeptide comprising the amino acid sequence of residues 1-90 of SEQ ID NO: 2, thereby causing said antibody to be produced and isolating said antibody.

2. A method of making an antibody that specifically binds to a C23 polypeptide comprising the amino acid sequence of residues 1-90 of SEQ ID NO: 2, said method comprising immunizing an immune system with an immunogenic amount of a C23 polypeptide comprising the amino acid sequence of residues 33-86 of SEQ ID NO: 2, thereby causing said antibody to be produced.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →